Qianggu capsule for the treatment of primary osteoporosis: evidence from a Chinese patent medicine

BACKGROUND: Qianggu Capsule, a Chinese patent medicine, has been widely applied in the clinical practice of primary osteoporosis (POP) in recent years. This study aims to summarize the effectiveness and safety of Qianggu Capsule in treating POP. METHODS: We searched seven electronic databases, all s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Xu, Xu, Aili, Shen, Hao, Xie, Yanming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307793/
https://www.ncbi.nlm.nih.gov/pubmed/28193278
http://dx.doi.org/10.1186/s12906-017-1617-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307793/
https://www.ncbi.nlm.nih.gov/pubmed/28193278
http://dx.doi.org/10.1186/s12906-017-1617-3

Ejemplares similares